Multiple sclerosis registries in Europe - Updated overview

In 2018, an updated mapping of multiple sclerosis (MS) registries in Europe was conducted, building on a previous survey from 2014. This survey covers 19 registries, mostly from Europe, and provides detailed information on the organisation, data collection methods, quality of control mechanisms and funding ...

A comparison of efficacy of subcutaneous interferon β-1a 44 μg, dimethyl fumarate and fingolimod in the real-life clinical practice – a multicenter observational study

Multiple sclerosis (MS) is a chronic inflammatory demyelinating and neurodegenerative disease affecting the central nervous system. Interferon (IFN) β-1a 44 μg, dimethyl fumarate (DMF), and fingolimod are established drugs for the treatment of relapsing-remitting MS (RR MS). The aim of this project, which involves analysis of data from the ReMuS registry, was to compare ...

ReMuS - The Czech Republic National Multiple Sclerosis Patient Registry

Article doc. Dana Horáková published in Multiple Sclerosis News offers a detailed look at the creation and development of the Czech national registry of multiple sclerosis patients, ReMuS, since its establishment in 2013. The reader will find information about the structure of the registry, the process of data collection,...